|
US3507866A
(en)
|
1967-08-08 |
1970-04-21 |
Merck & Co Inc |
1h - imidazo(4,5-b)pyrazin - 2 - one and processes for their preparation
|
|
BE788065A
(fr)
|
1971-08-26 |
1973-02-26 |
Degussa |
Nouvelles aza-benzimidazoles et procede pour leur preparation
|
|
IT1156732B
(it)
|
1978-05-10 |
1987-02-04 |
Roussel Maestretti Spa |
Derivati sostituiti dell'1,3-diidroimidazo(4,5-b)piridin-2-one e relativo procedimento di produzione
|
|
US4668686A
(en)
|
1985-04-25 |
1987-05-26 |
Bristol-Myers Company |
Imidazoquinoline antithrombrogenic cardiotonic agents
|
|
US4775674A
(en)
|
1986-05-23 |
1988-10-04 |
Bristol-Myers Company |
Imidazoquinolinylether derivatives useful as phosphodiesterase and blood aggregation inhibitors
|
|
US4943573A
(en)
|
1989-11-01 |
1990-07-24 |
Bristol-Myers Squibb Company |
Imidazo[4,5-b]quinolinyloxyalkanoic acid amides with enhanced water solubility
|
|
US5354759A
(en)
|
1991-09-12 |
1994-10-11 |
Fujisawa Pharmaceutical Co., Ltd. |
Angiotenin II antagonizing heterocyclic compounds
|
|
JPH0641135A
(ja)
|
1992-07-21 |
1994-02-15 |
Nippon Soda Co Ltd |
イミダゾプテリジン誘導体及びその製造方法
|
|
US6162804A
(en)
|
1997-09-26 |
2000-12-19 |
Merck & Co., Inc. |
Tyrosine kinase inhibitors
|
|
US6232320B1
(en)
|
1998-06-04 |
2001-05-15 |
Abbott Laboratories |
Cell adhesion-inhibiting antiinflammatory compounds
|
|
AU4231299A
(en)
|
1998-06-04 |
1999-12-20 |
Abbott Laboratories |
Cell adhesion-inhibiting antinflammatory compounds
|
|
KR100756592B1
(ko)
|
1999-10-08 |
2007-09-10 |
그뤼넨탈 게엠베하 |
비사이클릭 이미다조-3-일-아민 유도체, 이의 제조방법 및 이를 포함하는 진통제
|
|
HUP0203140A3
(en)
|
1999-10-08 |
2004-06-28 |
Gruenenthal Gmbh |
Bicyclic imidazo-5-yl-amine derivatives, process for their preparation and pharmaceutical compositions containing them
|
|
DE10050663A1
(de)
|
2000-10-13 |
2002-04-18 |
Gruenenthal Gmbh |
Verwendung von substituierten Imidazo[1,2-a]pyridin-, -pyrimidin- und pyrazin-3-yl-amin-Derivaten zur Herstellung von Medikamenten zur NOS-Inhibierung
|
|
US20040235801A1
(en)
*
|
2001-10-25 |
2004-11-25 |
Jean-Pierre Julien |
Therapy for stroke
|
|
US20030083318A1
(en)
|
2001-10-25 |
2003-05-01 |
Jean-Pierre Julien |
Therapy for neurodegenerative diseases
|
|
GB0206860D0
(en)
|
2002-03-22 |
2002-05-01 |
Glaxo Group Ltd |
Compounds
|
|
GB0212048D0
(en)
|
2002-05-24 |
2002-07-03 |
Merck Sharp & Dohme |
Therapeutic agents
|
|
US20040166137A1
(en)
|
2002-11-08 |
2004-08-26 |
Lackey John William |
Hetero-substituted benzimidazole compounds and antiviral uses thereof
|
|
GB2400101A
(en)
|
2003-03-28 |
2004-10-06 |
Biofocus Discovery Ltd |
Compounds capable of binding to the active site of protein kinases
|
|
JO2355B1
(en)
|
2003-04-15 |
2006-12-12 |
ميرك شارب اند دوم كوربوريشن |
Hereditary calcitonin polypeptide receptor antagonists
|
|
US7476665B2
(en)
|
2003-06-26 |
2009-01-13 |
Merck & Co., Inc. |
Benzodiazepine CGRP receptor antagonists
|
|
EP1646614A4
(en)
|
2003-07-01 |
2008-09-10 |
Merck & Co Inc |
OPHTHALMIC COMPOSITIONS FOR THE TREATMENT OF OCCULAR HYPERTONIA
|
|
EP1694323A4
(en)
|
2003-12-19 |
2009-05-13 |
Elixir Pharmaceuticals Inc |
METHOD FOR TREATING A DISEASE
|
|
EP1715855A4
(en)
|
2004-01-29 |
2010-06-16 |
Elixir Pharmaceuticals Inc |
ANTIVIRAL DRUGS
|
|
WO2005108374A1
(en)
|
2004-04-29 |
2005-11-17 |
Fmc Corporation |
Insecticidal diazole and triazole derivatives
|
|
GB0420719D0
(en)
|
2004-09-17 |
2004-10-20 |
Addex Pharmaceuticals Sa |
Novel allosteric modulators
|
|
AU2005289644A1
(en)
|
2004-09-24 |
2006-04-06 |
Janssen Pharmaceutica, N.V. |
Imidazo{4,5-b}pyrazinone inhibitors of protein kinases
|
|
MY179032A
(en)
|
2004-10-25 |
2020-10-26 |
Cancer Research Tech Ltd |
Ortho-condensed pyridine and pyrimidine derivatives (e.g.purines) as protein kinase inhibitors
|
|
CN101189238A
(zh)
|
2005-02-16 |
2008-05-28 |
先灵公司 |
具有cxcr3拮抗剂活性的哌嗪-哌啶
|
|
WO2007078815A2
(en)
|
2005-12-16 |
2007-07-12 |
Cytokinetics, Inc. |
Certain chemical entities, compositions, and methods
|
|
WO2007125321A2
(en)
|
2006-04-25 |
2007-11-08 |
Astex Therapeutics Limited |
Purine and deazapurine derivatives as pharmaceutical compounds
|
|
EP2037931A2
(en)
|
2006-04-25 |
2009-03-25 |
Astex Therapeutics Limited |
Pharmaceutical combinations of pk inhibitors and other active agents
|
|
WO2008016648A2
(en)
|
2006-08-01 |
2008-02-07 |
Cytokinetics, Incorporated |
Certain chemical entities, compositions and methods
|
|
US8227603B2
(en)
*
|
2006-08-01 |
2012-07-24 |
Cytokinetics, Inc. |
Modulating skeletal muscle
|
|
BRPI0714725B1
(pt)
*
|
2006-08-02 |
2021-05-25 |
Cytokinetics, Inc |
Entidade química, composição farmaceuticamente aceitável, e, uso de uma entidade química
|
|
CN101522681B
(zh)
*
|
2006-08-02 |
2012-10-03 |
赛特凯恩蒂克公司 |
特定的化学个体、组合物和方法
|
|
US8299248B2
(en)
|
2006-08-02 |
2012-10-30 |
Cytokinetics, Incorporated |
Certain 1H-imidazo[4,5-b]pyrazin-2(3H)-ones and 1H-imidazo[4,5-b]pyrazin-2-ols and methods for their use
|
|
CL2007002994A1
(es)
|
2006-10-19 |
2008-02-08 |
Wyeth Corp |
Compuestos derivados heterociclicos que contienen sulfamoilo, inhibidores de hsp90; composicion farmaceutica; y uso para el tratamiento del cancer, tal como cancer de mama, de colon y prostata, entre otros.
|
|
ES2627352T3
(es)
|
2006-10-19 |
2017-07-27 |
Signal Pharmaceuticals, Llc |
Compuestos heteroarilo, sus composiciones y su uso como inhibidores de proteínas quinasas
|
|
WO2008075007A1
(en)
|
2006-12-21 |
2008-06-26 |
Cancer Research Technology Limited |
Morpholino-substituted bicycloheteroaryl compounds and their use as anti cancer agents
|
|
ES2547303T3
(es)
|
2007-01-19 |
2015-10-05 |
Ardea Biosciences, Inc. |
Inhibidores de MEK
|
|
US7851484B2
(en)
|
2007-03-30 |
2010-12-14 |
Cytokinetics, Inc. |
Certain chemical entities, compositions, and methods
|
|
EP2018854A1
(en)
|
2007-07-27 |
2009-01-28 |
Merz Pharma GmbH & Co. KGaA |
Novel combinations of neramexane for the treatment of neurodegenerative disorders
|
|
US7998976B2
(en)
|
2008-02-04 |
2011-08-16 |
Cytokinetics, Inc. |
Certain chemical entities, compositions and methods
|
|
CA2713864A1
(en)
|
2008-02-04 |
2009-08-13 |
Cytokinetics, Incorporated |
Certain chemical entities, compositions and methods
|
|
CA2730473A1
(en)
|
2008-07-11 |
2010-01-14 |
Glaxo Group Limited |
Novel treatment
|
|
CN102264743B
(zh)
|
2008-11-25 |
2015-02-11 |
罗彻斯特大学 |
Mlk抑制剂及其使用方法
|
|
EP2228054A1
(en)
|
2009-03-13 |
2010-09-15 |
ITALFARMACO S.p.A. |
Riluzole aqueous suspensions
|
|
AU2010262970A1
(en)
|
2009-06-19 |
2012-01-12 |
Knopp Neurosciences, Inc. |
Compositions and methods for treating amyotrophic lateral sclerosis
|
|
WO2013151938A1
(en)
|
2012-04-02 |
2013-10-10 |
Cytokinetics, Inc. |
Methods for improving diaphragm function
|
|
BR112014025251B1
(pt)
|
2012-04-11 |
2021-03-02 |
Fady Malik |
uso de um ativador de troponina de músculo esquelético e composição compreendendo o mesmo
|
|
LT3137622T
(lt)
|
2014-04-29 |
2022-04-25 |
Cytokinetics, Inc. |
Gyvybinio pajėgumo nykimo mažinimo būdai
|